Clearance of abnormal IGA1 in IGA1 deposition diseases

• 1. IgA1沉积疾病的治疗 [P] . 中国专利： CN1777673B . 2010.04.28
• 2. IgA1沉积疾病的治疗 [P] . 中国专利： CN1777673A . 2006-05-24
• 3. CLEARANCE OF ABNORMAL IGA1 IN IGA1 DEPOSITION DISEASES [P] . 美国专利： US2009317381A1 . 2009-12-24

  机译： IGA1沉积疾病中IGA1异常的清除

• 4. CLEARANCE OF ABNORMAL IGA1 IN IGA1 DEPOSITION DISEASES [P] . 世界知识产权组织专利： WO2007061936A3 . 2009-05-07

  机译： IGA1沉积疾病中IGA1异常的清除

• 5. CLEARANCE OF ABNORMAL IGA1 IN IGA1 DEPOSITION DISEASES [P] . 世界知识产权组织专利： WO2007061936A2 . 2007-05-31

  机译： IGA1沉积疾病中IGA1异常的清除

• 1. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89|[ndash]|IgA and IgG|[ndash]|IgA complexes: common mechanisms for distinct diseases [J] . Emilie Tissandié, Willy Morelle, Laureline Berthelot, Kidney international. . 2011,第12期
• 2. Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy [J] . SerinoG., SallustioF., CoxS.N., Journal of the American Society of Nephrology: JASN . 2012,第5期
• 3. Abnormal miR-148b Expression Promotes Aberrant Glycosylation of IgA1 in IgA Nephropathy [J] . Grazia Serino, Fabio Sallustio, Sharon N. Cox, Journal of the American Society of Nephrology: JASN . 2012,第5期
• 4. Mass spectrometric approach for characterization of kinetics and site-specificity of a glycosyltransferase initiating O-glycosylation of IgA1 hinge region [C] . Kazuo Takahashi, Milada Horynova, Milan Raska, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011
• 5. Roles of brain proteoglycans and neuroglia in amyloid-beta (Abeta) deposition and clearance in Alzheimer's disease. [D] . Fralich, Thomas John. 2009
• 6. IgA Nephropathy Caused by Unusual Polymerization of IgA1 with Aberrant N-Glycosylation in a Patient with Monoclonal Immunoglobulin Deposition Disease [O] . Yoshiki Narimatsu, Atsushi Kuno, Hiromi Ito, -1
• 7. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89–IgA and IgG–IgA complexes: common mechanisms for distinct diseases [O] . Tissandié Emilie, Morelle Willy, Berthelot Laureline, 2011

• 1. 血清低半乳糖化IgA1测定鉴别IgA1肾病的临床研究 [J] . 邱晓峰 . 临床和实验医学杂志 . 2008,第012期
• 2. 人系膜细胞IgA1受体及IgA1分子铰链区糖基化改变的研究进展 [J] . 胡瑞海 ,赵明辉 . 医学综述 . 2005,第003期
• 3. 利用细菌产生IgA1蛋白酶测定IgA1 [J] . 张颖 ,刘连生 . 徐州医学院学报 . 1992,第001期
• 4. 过敏性紫癜患儿IgA1免疫复合物对中性粒细胞激活及CD89表达的影响 [J] . 郭婷 ,李宇宁 ,凌继祖 . 兰州大学学报（医学版） . 2021,第001期
• 5. 沉默HMGB1基因对HSP患儿血清IgA1诱导血管内皮细胞凋亡、通透性的影响及机制 [J] . 马立显 ,侯海燕 ,侯艳梅 . 山东医药 . 2021,第007期
• 6. IgA1异常糖基化及肝细胞生长因子与腹型过敏性紫癜患儿胃肠道损伤关系的研究 [C] . 余强 ,傅睿 . 中华医学会第十八次全国儿科学术会议 . 2013
• 7. IgA1在IgA肾病中发病机制的研究进展 [A] . 齐小蜜 . 2016